Apellis Has New Hope for Pegcetacoplan With Longer-Term Data

18-Month Results Could Vindicate Geographic Atrophy Program

Eye
Apellis announced longer-term data for pegcetacoplan in geographic atrophy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Sensory

More from Therapeutic Category